Watch the July 23 PCAC meeting
FDA awarded national priority voucher under the Commissioners National Priority Voucher (CNPV) pilot program to a trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate for its potential to increase access through affordability for American patients
Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement
Combination Therapies and Fixed-Dose Formulations: The pharmaceutical field continues to innovate fixed-dose combination products that combine GLP-1 receptor agonists with complementary actions, such as basal insulin, SGLT-2 inhibitors, and metformin, to achieve complete metabolism with a single injection or tablet
Arctigenin may have a potential role in treating IgE-mediated food and other allergic diseases
Expression of mt-roGFP in park 13 tyrosine hydroxylase positive neurons showed significantly reduced mitochondrial ROS accumulation under Sp treatment as compared to untreated ones, highlighting potential mitochondrial recovery and prevention of oxidation induced cell death in dopamine producing neurons (Fig
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
